These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18097548)

  • 1. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
    Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
    Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas.
    Yarbrough WG; Whigham A; Brown B; Roach M; Slebos R
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S98-101. PubMed ID: 17848307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
    Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
    Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma.
    Hoa M; Davis SL; Ames SJ; Spanjaard RA
    Cancer Res; 2002 Dec; 62(24):7154-6. PubMed ID: 12499248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIK3CA mutation and amplification in human lung cancer.
    Okudela K; Suzuki M; Kageyama S; Bunai T; Nagura K; Igarashi H; Takamochi K; Suzuki K; Yamada T; Niwa H; Ohashi R; Ogawa H; Mori H; Kitamura H; Kaneko T; Tsuneyoshi T; Sugimura H
    Pathol Int; 2007 Oct; 57(10):664-71. PubMed ID: 17803655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.
    Woenckhaus J; Steger K; Werner E; Fenic I; Gamerdinger U; Dreyer T; Stahl U
    J Pathol; 2002 Nov; 198(3):335-42. PubMed ID: 12375266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
    Yarbrough WG
    Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
    Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
    Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme.
    Gallia GL; Rand V; Siu IM; Eberhart CG; James CD; Marie SK; Oba-Shinjo SM; Carlotti CG; Caballero OL; Simpson AJ; Brock MV; Massion PP; Carson BS; Riggins GJ
    Mol Cancer Res; 2006 Oct; 4(10):709-14. PubMed ID: 17050665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.
    Hayes MP; Wang H; Espinal-Witter R; Douglas W; Solomon GJ; Baker SJ; Ellenson LH
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5932-5. PubMed ID: 17062663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.
    Maruyama N; Miyoshi Y; Taguchi T; Tamaki Y; Monden M; Noguchi S
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):408-14. PubMed ID: 17202311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase.
    Carson JD; Van Aller G; Lehr R; Sinnamon RH; Kirkpatrick RB; Auger KR; Dhanak D; Copeland RA; Gontarek RR; Tummino PJ; Luo L
    Biochem J; 2008 Jan; 409(2):519-24. PubMed ID: 17877460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma.
    Worsham MJ; Pals G; Schouten JP; Van Spaendonk RM; Concus A; Carey TE; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):702-8. PubMed ID: 12874067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA mutations in head and neck squamous cell carcinoma.
    Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
    Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
    Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
    Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of the PIK3CA gene in ovarian and breast cancer.
    Campbell IG; Russell SE; Choong DY; Montgomery KG; Ciavarella ML; Hooi CS; Cristiano BE; Pearson RB; Phillips WA
    Cancer Res; 2004 Nov; 64(21):7678-81. PubMed ID: 15520168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.
    Hollestelle A; Elstrodt F; Nagel JH; Kallemeijn WW; Schutte M
    Mol Cancer Res; 2007 Feb; 5(2):195-201. PubMed ID: 17314276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
    Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
    Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.